Oryzon recibe el Premio Pyme del Año 2026 en la categoría 'Digitalización e Innovación'

by Oryzon Genomics

El galardón convierte a Oryzon en una de las cinco ganadoras de la provincia de Barcelona en la décima edición de estos premios, organizados por Banco Santander y la Cámara de Comercio de España

Read more

ORYZON raises €12 million and signs a financing agreement with COFIDES to strengthen its balance sheet and accelerate its clinical programs

by Oryzon Genomics

The Social Impact Fund, managed by COFIDES, has committed to invest €25 million in future capital increases to support Oryzon's mental health programs, subject to certain conditions

Read more

Una propuesta de medicina de precisión en salud mental de Oryzon recibe la distinción de Proyecto de Alta Calidad del programa europeo Eurostars

by Oryzon Genomics

La propuesta ha superado favorablemente todas las fases de la evaluación internacional, incluida la revisión por parte del Independent Evaluation Panel (IEP)

Read more

ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress

by Oryzon Genomics

In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity, with 100% (18/18) ORR, 89% (16/18) CRc and 78% (14/18) CR, and continued to demo...

Read more

ORYZON initiates patient enrollment in IDEAL Phase II trial of iadademstat in essential thrombocythemia

by Oryzon Genomics

Oryzon Genomics a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the first patient has been enrolled in IDEAL, its Phase II study evaluating iadadems...

Read more

ORYZON reports financial results and corporate update for quarter ended March 31st, 2026

by Oryzon Genomics

Updated positive data from iadademstat in 1L AML unfit patients to be presented at EHA, with 100% ORR, 93% CRc and 79% strict CR at abstract submission cut-off

Read more

ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026

by Oryzon Genomics

In first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a composite complete remission rate (CRc) of 93% (with 79% CR), and an estimated 12-mon...

Read more

ORYZON to participate in upcoming events in May and June

by Oryzon Genomics

Updated data from iadademstat’s clinical trials in acute myeloid leukemia to be presented at EHA-2026 in June

Read more

ORYZON strengthens vafidemstat patent portfolio with U.S. Notice of Allowance

by Oryzon Genomics

Covers the use of vafidemstat for treating non-aggressive symptoms of Borderline Personality Disorder

Read more

ORYZON announces U.S. patent grant covering iadademstat combinations with venetoclax

by Oryzon Genomics

Oryzon Genomics today announced that the United States Patent and Trademark Office has granted U.S. patent US12,564,559 B2, relating to therapeutic combinations of iadademstat, Oryzon’s potent and s...

Read more

ORYZON expands patent protection for iadademstat with grant decision in Mexico covering combinations with PD-1/PD-L1 inhibitors

by Oryzon Genomics

Oryzon Genomics today announced that the Mexican Patent Office has issued a decision to grant for its patent application MX/a/2021/011610, entitled “Combinations of iadademstat for cancer therapy”...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Heat Exposure During Pregnancy and Infan...

by ISGlobal - Instituto de Salud Global de Barcelona

New study finds an association between higher temperatures early in li...

Photos Stream